617539

Janssen Biotech Inc. — FEI 3006473233

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 2, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Horsham, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)